SPECIALTY TOPICS · GUIDE
Enzymes and Peptide Breakdown
How peptidase enzymes break peptides apart in the gut, blood and organs, and how medicine makers slow that down, with DPP-4 and GLP-1 as the worked example.
Content last updated . This page has not been medically reviewed.
Back to Peptides & Modern ResearchWhy peptides do not last
Peptides are short chains of amino acids joined by peptide bonds. Enzymes called peptidases cut those bonds. The body uses them to recycle protein and to switch signals off. That is helpful for a natural hormone, which should act and then stop. It is a problem for a peptide medicine, which may be cleared before it can do much. [1]A review of peptide metabolism says peptidases are spread widely through the body. The liver, kidney, gut and blood are the main sites, and the lung, skin, placenta and nasal lining can also break peptides down. [1]
A worked example: GLP-1 and DPP-4
GLP-1 is a natural gut hormone that helps control blood sugar. The liraglutide label says natural GLP-1 has a half-life of 1.5 to 2 minutes because the enzymes dipeptidyl peptidase IV (DPP-IV, also written DPP-4) and neutral endopeptidases break it down. [2]Medicines handle this problem in two different ways.
| Approach | Example | What the label says |
|---|---|---|
| Change the peptide so enzymes cannot cut it as easily | Liraglutide | It is stable against breakdown by both peptidases and has a half-life of 13 hours after injection under the skin [2] |
| Change the peptide, and add protection | Semaglutide | It is stabilized against DPP-4, and binding to albumin gives protection from metabolic degradation and lower kidney clearance [3] |
| Leave the peptide alone and block the enzyme | Sitagliptin (an enzyme blocker) | It is a DPP-4 inhibitor that slows the inactivation of incretin hormones, so active natural hormone levels rise [4] |
The third row matters for reading claims. Blocking a peptide-cutting enzyme is a different idea from giving a peptide, and each has its own evidence and its own risks.
How makers slow breakdown
The reviews describe a toolkit: changing the ends of the chain, swapping in D-amino acids or unnatural amino acids, forming rings (cyclization), changing the backbone, using nanoparticle formulations and making the molecule larger. [1] A 2023 review lists chemical modifications such as cyclization, D-amino acid substitution, N-methylation and side-chain halogenation, and also delivery systems. [5]Real products show the idea. Degarelix, a peptide antagonist, is broken down by peptide hydrolysis as it passes through the liver and bile system, and is mainly excreted as peptide fragments in the feces. [6] The semaglutide label describes the main route of elimination as proteolytic cleavage of the peptide backbone, plus breakdown of a fatty-acid side chain. [3] So modified peptides are still broken down, just more slowly.
Digestion is the biggest barrier
Food proteins are meant to be digested, so the gut is full of enzymes. A review of oral peptide delivery notes that the harsh gut environment and poorly penetrating gut lining often leave oral bioavailability under 1% to 2%. [7] The page on bioavailability covers this, and why peptides are often broken down during digestion goes deeper.What this means for claims
- "Stable" needs a measurement. A product page saying a peptide resists breakdown is a claim about enzymes. The evidence is a laboratory or human study of that exact molecule. Stability seen with one modified peptide does not carry over to another.
- Breakdown is not the same as clearance. Enzymes cut the peptide, while the kidney and liver remove fragments. See half-life and clearance.
- Modification changes more than stability. A change that protects against enzymes can also alter how a molecule binds, how long it stays and how the immune system sees it. See why molecular structure matters.
- Storage and handling. How peptides degrade outside the body is a separate subject; see stability and storage science.
This page is education only and gives no use instructions.
Frequently asked questions
What is a peptidase?
It is an enzyme that cuts the bonds between amino acids in a peptide or protein. Peptidases are found in many organs, including the liver, kidney, gut lining and blood. [1]
Why is natural GLP-1 so short-lived?
The liraglutide label says it has a half-life of 1.5 to 2 minutes because DPP-IV and neutral endopeptidases degrade it. [2]
Do modified peptides escape breakdown completely?
No. The semaglutide and degarelix labels both describe elimination through peptide breakdown. The change is in speed, not in whether it happens. [3][6]
Is a DPP-4 inhibitor a peptide?
Sitagliptin, the example in its label, is described as an enzyme inhibitor that slows the inactivation of incretin hormones. It acts on the enzyme rather than supplying the hormone. [4]
References
- Yao JF, et al. Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability. Curr Drug Metab. 2018. PubMed 29956618 (abstract). Read 2026-10-22.
- U.S. FDA prescribing information, Victoza (liraglutide), sections 12.1 and 12.3, label effective 2023-02-06, read as the FDA label record at openFDA drug label API. Read 2026-10-22.
- U.S. FDA prescribing information, oral semaglutide tablets (RYBELSUS and OZEMPIC tablets), sections 12.1 and 12.3, label effective 2026-01-30, read as the FDA label record at openFDA drug label API. Read 2026-10-22.
- U.S. FDA prescribing information, Januvia (sitagliptin), section 12.1, label effective 2026-07-08, read as the FDA label record at openFDA drug label API. Read 2026-10-22.
- Fetse J, et al. Recent advances in the development of therapeutic peptides. Trends Pharmacol Sci. 2023. PubMed 37246037 (abstract). Read 2026-10-22.
- U.S. FDA prescribing information, Firmagon (degarelix), section 12, label effective 2024-01-30, read as the FDA label record at openFDA drug label API. Read 2026-10-22.
- Han Y, et al. Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins. Acta Pharm Sin B. 2019. PubMed 31649842 (abstract). Read 2026-10-22.